PETRUCCI, FLAVIA
PETRUCCI, FLAVIA
DIPARTIMENTO DI SANITA' PUBBLICA E MALATTIE INFETTIVE
Antibiotic-loaded hydrogel for the treatment of lower-limb fracture-related infections: a single center’s multidisciplinary experience
2024 DE MEO, Daniele; Martini, Paolo; LO TORTO, Federico; Petrucci, Flavia; ORDONEZ REYNA, JESSICA NICOLE; Candela, Vittorio; Iaiani, Giancarlo; Oliva, Alessandra; Ribuffo, Diego; Gumina, Stefano
Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study
2024 Oliva, Alessandra; Liguori, L; Covino, S; Petrucci, F; Cogliati-Dezza, F; Curtolo, A; Savelloni, G; Comi, M; Sacco, F; Ceccarelli, G; Viscido, A; Alessandri, F; Raponi, G; Pugliese, F; Mastroianni, C M; Venditti, M
Compassionate use of cefiderocol in a complex case of extensively drug-resistant Acinetobacter baumannii fracture-related infection: a comprehensive approach and multidisciplinary management
2024 Petrucci, Flavia; Perciballi, Beatrice; Rivano Capparuccia, Marco; Iaiani, Giancarlo; Lo Torto, Federico; Ribuffo, Diego; Gumina, Stefano; De Meo, Daniele
Effect of secondary infections on the outcomes of patients with hematological malignancies and SARS-CoV-2 infection results from the HM-COV 3.0 study
2025 Petrucci, Flavia; Pellicano, Chiara; Cogliati Dezza, Francesco; Valeri, Serena; Covino, Sara; Iannazzo, Francesco; Infante, Francesca; Gigante, Antonietta; Sacco, Federica; Viscido, Agnese; Iacovelli, Alessandra; Rosato, Edoardo; Palange, Paolo; Mastroianni, Claudio Maria; Oliva, Alessandra
Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study
2023 Oliva, Alessandra; COGLIATI DEZZA, Francesco; Petrucci, Flavia; Romani, FRANCESCO EUGENIO; Morviducci, Matteo; Mirabelli, Flavio Marco; Cancelli, Francesca; Valeriani, Emanuele; Marcelli, Giulia; Pugliese, Francesco; Turriziani, Ombretta; Ricci, Paolo; Venditti, Mario; Palange, Paolo; Mastroianni, Claudio Maria
Risk factors for carbapenem-resistant Acinetobacter baumannii (crab) bloodstream infections and related mortality in critically ill patients with (crab) colonization
2023 Cogliati Dezza, Francesco; Covino, Sara; Petrucci, Flavia; Sacco, Federica; Viscido, Agnese; Gavaruzzi, Francesca; Ceccarelli, Giancarlo; Raponi, Gianmarco; Borrazzo, Cristian; Alessandri, Francesco; Mastroianni, Claudio Maria; Venditti, Mario; Oliva, Alessandra
Using Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in obese patients. A real-life, single-center observational study
2025 Oliva, Alessandra; Petrucci, Flavia; Leanza, Cristiana; Rivano Capparuccia, Marco; Comi, Michela; Mastroianni, Claudio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antibiotic-loaded hydrogel for the treatment of lower-limb fracture-related infections: a single center’s multidisciplinary experience | 2024 | DE MEO, Daniele; Martini, Paolo; LO TORTO, Federico; Petrucci, Flavia; ORDONEZ REYNA, JESSICA NICOLE; Candela, Vittorio; Iaiani, Giancarlo; Oliva, Alessandra; Ribuffo, Diego; Gumina, Stefano | |
| Clinical effectiveness of cefiderocol for the treatment of bloodstream infections due to carbapenem-resistant Acinetobacter baumannii during the COVID-19 era. A single center, observational study | 2024 | Oliva, Alessandra; Liguori, L; Covino, S; Petrucci, F; Cogliati-Dezza, F; Curtolo, A; Savelloni, G; Comi, M; Sacco, F; Ceccarelli, G; Viscido, A; Alessandri, F; Raponi, G; Pugliese, F; Mastroianni, C M; Venditti, M | |
| Compassionate use of cefiderocol in a complex case of extensively drug-resistant Acinetobacter baumannii fracture-related infection: a comprehensive approach and multidisciplinary management | 2024 | Petrucci, Flavia; Perciballi, Beatrice; Rivano Capparuccia, Marco; Iaiani, Giancarlo; Lo Torto, Federico; Ribuffo, Diego; Gumina, Stefano; De Meo, Daniele | |
| Effect of secondary infections on the outcomes of patients with hematological malignancies and SARS-CoV-2 infection results from the HM-COV 3.0 study | 2025 | Petrucci, Flavia; Pellicano, Chiara; Cogliati Dezza, Francesco; Valeri, Serena; Covino, Sara; Iannazzo, Francesco; Infante, Francesca; Gigante, Antonietta; Sacco, Federica; Viscido, Agnese; Iacovelli, Alessandra; Rosato, Edoardo; Palange, Paolo; Mastroianni, Claudio Maria; Oliva, Alessandra | |
| Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies. Results from the HM-COV 2.0 study | 2023 | Oliva, Alessandra; COGLIATI DEZZA, Francesco; Petrucci, Flavia; Romani, FRANCESCO EUGENIO; Morviducci, Matteo; Mirabelli, Flavio Marco; Cancelli, Francesca; Valeriani, Emanuele; Marcelli, Giulia; Pugliese, Francesco; Turriziani, Ombretta; Ricci, Paolo; Venditti, Mario; Palange, Paolo; Mastroianni, Claudio Maria | |
| Risk factors for carbapenem-resistant Acinetobacter baumannii (crab) bloodstream infections and related mortality in critically ill patients with (crab) colonization | 2023 | Cogliati Dezza, Francesco; Covino, Sara; Petrucci, Flavia; Sacco, Federica; Viscido, Agnese; Gavaruzzi, Francesca; Ceccarelli, Giancarlo; Raponi, Gianmarco; Borrazzo, Cristian; Alessandri, Francesco; Mastroianni, Claudio Maria; Venditti, Mario; Oliva, Alessandra | |
| Using Dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in obese patients. A real-life, single-center observational study | 2025 | Oliva, Alessandra; Petrucci, Flavia; Leanza, Cristiana; Rivano Capparuccia, Marco; Comi, Michela; Mastroianni, Claudio |